Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Administration Aids”

282 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 282 results

Testing effectiveness (Phase 2)Study completedNCT02054286
What this trial is testing

Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).

Who this might be right for
HIV Infection
Theravectys S.A. 38
Early research (Phase 1)Study completedNCT00002196
What this trial is testing

CI-1012 in HIV-Infected Patients

Who this might be right for
HIV Infections
Parke-Davis 32
Early research (Phase 1)Study completedNCT00002427
What this trial is testing

Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults

Who this might be right for
HIV Infections
Research Institute for Genetic and Human Therapy 225
Large-scale testing (Phase 3)Study completedNCT00262106
What this trial is testing

Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection

Who this might be right for
HIV InfectionsGonorrheaChlamydial Infections+1 more
Endo USA Inc., a Keenova Therapeutics Company 9,404
Large-scale testing (Phase 3)Study completedNCT01968551
What this trial is testing

Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

Who this might be right for
HIV-1HIV InfectionsAcquired Immunodeficiency Syndrome
Gilead Sciences 158
Large-scale testing (Phase 3)Study completedNCT00294164
What this trial is testing

Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)

Who this might be right for
Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)Human Immunodeficiency Virus Infections
EMD Serono 245
Testing effectiveness (Phase 2)Study completedNCT00294892
What this trial is testing

Pharmacokinetics Study on Nevirapine Resistance in Tanzania

Who this might be right for
HIV Infections
Radboud University Medical Center 144
Large-scale testing (Phase 3)Study completedNCT00489528
What this trial is testing

Growth Hormone in the Treatment of HIV-Associated Wasting

Who this might be right for
HIV InfectionsHIV Wasting Syndrome
EMD Serono
Testing effectiveness (Phase 2)Ended earlyNCT04493216
What this trial is testing

A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive Adults

Who this might be right for
HIV Infections
ViiV Healthcare 161
Testing effectiveness (Phase 2)Study completedNCT00036634
What this trial is testing

A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients

Who this might be right for
HIV Infections
Gilead Sciences 30
Not applicableNot Yet RecruitingNCT07175545
What this trial is testing

Testing a Smart Medication Dispenser (Mobili®) to Help People With Chronic Conditions Take Their Medicine

Who this might be right for
Dose Administration AidsMedication AdherencePolypharmacy+3 more
Lusofona University 96
Large-scale testing (Phase 3)Study completedNCT03227861
What this trial is testing

Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care

Who this might be right for
HIV-1
Janssen Scientific Affairs, LLC 109
Early research (Phase 1)Study completedNCT04799353
What this trial is testing

Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV)

Who this might be right for
Human Immunodeficiency Virus (HIV)
AbbVie 33
Large-scale testing (Phase 3)Study completedNCT00000903
What this trial is testing

Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 444
Testing effectiveness (Phase 2)Study completedNCT00412646
What this trial is testing

TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients

Who this might be right for
Anti-Retroviral AgentsHIV-1
Tibotec Pharmaceuticals, Ireland 260
Not applicableStudy completedNCT00002203
What this trial is testing

Two Anti-HIV Drug Combinations

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT00052117
What this trial is testing

Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens

Who this might be right for
HIV Infections
Pfizer 300
Early research (Phase 1)Study completedNCT02658968
What this trial is testing

Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)

Who this might be right for
Relapsed, Diffuse Large B-cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
Nordic Nanovector 18
Early research (Phase 1)Study completedNCT04223804
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1

Who this might be right for
Human Immunodeficiency Virus (HIV)HIV InfectionHIV-1
AbbVie 41
Early research (Phase 1)Study completedNCT05933824
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LP-98 Injection in Healthy Subjects

Who this might be right for
HIV (Human Immunodeficiency Virus)
Shanxi Kangbao Biological Product Co., Ltd. 36
Next Page